[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2014 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-Nov-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Sep-2014 [#3]
Profit Trend
QoQ- 35.45%
YoY- 66.19%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Revenue 1,710,764 1,606,206 1,509,162 1,495,830 1,378,779 1,329,942 1,153,195 6.78%
PBT 53,198 67,948 89,005 87,726 59,990 99,066 56,818 -1.09%
Tax -20,299 -21,189 -20,462 -30,122 -24,496 -28,392 -16,215 3.81%
NP 32,899 46,759 68,543 57,604 35,494 70,674 40,603 -3.44%
-
NP to SH 32,023 46,435 67,982 57,147 34,387 69,645 40,215 -3.72%
-
Tax Rate 38.16% 31.18% 22.99% 34.34% 40.83% 28.66% 28.54% -
Total Cost 1,677,865 1,559,447 1,440,619 1,438,226 1,343,285 1,259,268 1,112,592 7.08%
-
Net Worth 531,892 530,907 534,070 507,513 473,857 496,623 464,307 2.28%
Dividend
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Div 33,729 33,667 59,542 41,429 25,427 29,420 - -
Div Payout % 105.33% 72.50% 87.59% 72.50% 73.95% 42.24% - -
Equity
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Net Worth 531,892 530,907 534,070 507,513 473,857 496,623 464,307 2.28%
NOSH 259,821 258,979 258,880 258,935 258,938 117,683 106,983 15.92%
Ratio Analysis
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
NP Margin 1.92% 2.91% 4.54% 3.85% 2.57% 5.31% 3.52% -
ROE 6.02% 8.75% 12.73% 11.26% 7.26% 14.02% 8.66% -
Per Share
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 659.36 620.21 582.96 577.69 532.47 1,130.10 1,077.92 -7.85%
EPS 12.34 17.93 26.26 22.07 13.28 59.18 37.59 -16.92%
DPS 13.00 13.00 23.00 16.00 9.82 25.00 0.00 -
NAPS 2.05 2.05 2.063 1.96 1.83 4.22 4.34 -11.74%
Adjusted Per Share Value based on latest NOSH - 258,737
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
RPS 118.70 111.45 104.71 103.79 95.67 92.28 80.01 6.78%
EPS 2.22 3.22 4.72 3.97 2.39 4.83 2.79 -3.73%
DPS 2.34 2.34 4.13 2.87 1.76 2.04 0.00 -
NAPS 0.3691 0.3684 0.3706 0.3521 0.3288 0.3446 0.3222 2.28%
Price Multiplier on Financial Quarter End Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 28/09/12 30/09/11 -
Price 4.14 5.58 6.50 4.63 4.82 7.55 5.90 -
P/RPS 0.63 0.90 1.12 0.80 0.91 0.67 0.55 2.28%
P/EPS 33.54 31.12 24.75 20.98 36.30 12.76 15.70 13.47%
EY 2.98 3.21 4.04 4.77 2.76 7.84 6.37 -11.88%
DY 3.14 2.33 3.54 3.46 2.04 3.31 0.00 -
P/NAPS 2.02 2.72 3.15 2.36 2.63 1.79 1.36 6.80%
Price Multiplier on Announcement Date
30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 CAGR
Date 15/11/17 21/11/16 26/11/15 21/11/14 19/11/13 06/11/12 01/11/11 -
Price 3.82 5.70 6.50 4.45 4.72 8.25 5.90 -
P/RPS 0.58 0.92 1.12 0.77 0.89 0.73 0.55 0.88%
P/EPS 30.95 31.79 24.75 20.16 35.54 13.94 15.70 11.96%
EY 3.23 3.15 4.04 4.96 2.81 7.17 6.37 -10.69%
DY 3.40 2.28 3.54 3.60 2.08 3.03 0.00 -
P/NAPS 1.86 2.78 3.15 2.27 2.58 1.95 1.36 5.35%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment